In Britain, young people under the age of 30 will not get the AstraZeneca vaccine
People under the age of 30 in Britain will be offered the Pfizer or Moderna vaccine, not the Oxford / AstraZeneca vaccine, due to concerns about very rare cases of blood clots.
The Regulatory Agency for Drugs and Health Products (MHRA) in Britain has stated that the vaccine still has great benefits in preventing Covid-19 and has not concluded that the vaccine causes rare clots, however it adds that there is some evidence raising concerns. .
June Raine, MHRA chief executive said at the conference today that cases of blood clots are in fact very rare, while the benefits of the vaccine are known.
"The evidence is getting stronger and our review has concluded that while it is a strong possibility, more work is needed to prove beyond any doubt that the vaccine has caused these side effects."
The day before the European Medicines Agency showed that there is in fact a connection of blood clotting with AstraZeneca, but that these effects occurred very rarely and in an unusual way, as it is not known what causes it specifically.